Envoy Medical (NASDAQ:COCHW – Get Free Report) is anticipated to post its results before the market opens on Thursday, November 5th. Analysts expect the company to post earnings of ($0.6733) per share and revenue of $0.09 million for the quarter.
Envoy Medical Price Performance
COCHW stock opened at $0.03 on Thursday. The firm has a 50 day simple moving average of $0.04 and a 200-day simple moving average of $0.05. Envoy Medical has a twelve month low of $0.02 and a twelve month high of $0.10.
About Envoy Medical
Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technologies are designed to use the body’s natural anatomy to capture sound and deliver auditory stimulation, with the goal of providing hearing restoration without the external components required by many conventional hearing devices.
Envoy Medical’s lead product is the Acclaim cochlear implant, a fully implanted device intended for adults with sensorineural hearing loss who may benefit from cochlear implantation.
Further Reading
- Five stocks we like better than Envoy Medical
- Garmin Raises Its Profit OutlookâCan the Stock Reach New Highs?
- Why Rising Rates Could Break the Bull Market Before AI Spending Can Save It
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
